Groowe BETA / Newsroom

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

CAPR Stock Drop Alert: Capricor Therapeutics Stock Plummets Over 64% After FDA Briefing Documents Raise Concerns, Triggering Securities Fraud Investigation by BFA Law

businesswire.com July 30, 2026 at 11:09 AM ET

CAPR The stock plummeted over 64% following FDA briefing documents that raised concerns, leading to a securities fraud investigation. This indicates significant negative developments.